Expansion into Canada, medical marijuana in Mexico, and investment opportunities with Medical Marijuana, Inc. top the stories from our family of companies this week.
Medical Marijuana, Inc. and our family of companies were once again in the news as international expansion of legal cannabis dominated the recent news cycle. Keep reading to get the highlights from Medical Marijuana, Inc.’s week.
Raul Elizalde Interviewed by Forbes
Mexico’s growing national medical marijuana program and the role of CBD and Medical Marijuana, Inc.’s subsidiary HempMeds® Mexico was at the center of a Forbes article published last week.
In the article, HempMeds® President, Latin America, Raul Elizalde was interviewed to give insight into the developing medical cannabis program in Mexico and how CBD is being used within it.
CBD extracts “with below 1% THC content can be in medicine, supplements, lotions, food, anything. This is very, very good for our country, and I think we’re one of the very first in the world to take that path,” Elizalde told Forbes.
HempMeds® Mexico currently distributes the Real Scientific Hemp Oil (RSHO) line of CBD products to customers in the country. Made with low THC hemp oil or THC-free CBD isolate, RSHO products fit within this restriction.
“The Mexican government understands that CBD is not a danger to public health, so regulating quantity just doesn’t make sense,” Elizalde said. It is only THC levels that concern the government in Mexico.
“Nobody buys CBD to get high, nobody buys it to try to abuse it, and the only thing that will happen if it’s scheduled [as a controlled substance] is that it will become a black-market drug. But it’s not a drug,” he added. “It’s a supplement.”
You can learn more about HempMeds® Mexico here.
Cannabis in Canada
Entrepreneur Magazine ran an article this past week that sought to explore the global ramifications of Canada’s recreational marijuana legalization.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc., was interviewed first for the piece in order to give some background into the significance of Canada’s move, saying it was a “total game-changer for the overall cannabis industry.” Canada’s legalization of recreational cannabis is sure to have global effects. Canada is the first G-7 country to fully legalize cannabis and the second overall after Uruguay.
Medical Marijuana, Inc. has taken steps to enter into this billion dollar market, including signing a Letter of Intent with Canadian company Salvation Botanicals and hiring a Director of Canadian Operations. You can find more about Medical Marijuana, Inc.’s Canadian efforts here.
Coverage of this news was also provided by these sites:
Medical Marijuana, Inc. as an Investment Opportunity
Several news outlets this week listed Medical Marijuana, Inc. as a possible place for investors to get started investing in the legal cannabis industry.
In a story looking at the potential legalization of all cannabis in Mexico, Green Rush Daily mentioned that Medical Marijuana, Inc. is already a part of Mexico’s medical cannabis industry, making us a smart choice for investors. In fact, THC-free RSHO-X from HempMeds® Mexico was the first cannabis-based product legally distributed in the country. This news was also featured in Energy & Capital.
In response to Medical Marijuana, Inc.’s year over year growth and high book to market ratio, Buckner Business Daily has listed Medical Marijuana, Inc. as an undervalued stock worth considering for portfolios.
You can find more about investing in Medical Marijuana, Inc. here.
Read More Medical Marijuana, Inc. News
Visit our news feed to stay up-to-date with the latest from our family of companies.
>View original article
Author: Jeffrey Stamberger